European Commission proposes a unified market for medicines and incentives for antibiotic development to address drug shortages in EU

The European Commission has recently put forth a proposal to amend the EU pharmaceutical legislation on April 26, 2023 (available at https://health.ec.europa.eu/system/files/2023-04/com_2023_193_1_act_en.pdf). This proposed revision aims to establish a unified market for medicines across all EU member states, thereby promoting greater accessibility to novel and effective drugs while also tackling...

Spain becomes a benchmark in Europe in the fight against antimicrobial resistance thanks to PROA certification standard

Global increase in antimicrobial resistance and complexity of infectious disease make it essential to establish Antimicrobial Use Optimization Programs (PROA) in the community and hospital areas. These programs have the objective of optimizing prescription of antibiotics, guaranteeing optimal clinical results, minimizing adverse effects derived from their use, controlling the appearance...